MetaVia Inc.
- Last sale
- Nov 12, 2026 · -10.62%
- Market cap
- $8.80M
- 6.74M shares
- Filings
- 638
—
—
—Q3 2026N/M FY25 yoy
Q3 2026N/M FY25 yoy
Q3 2026derivedN/M FY25 yoy
Q3 2026N/M FY25 yoy
Q3 2026−35.8% FY25 yoy
- $8.80M
- —
- —
- 3.6×
- -178.45%
- —
FY2025 figures · derived
Price
Nov 12, 2026 · IEX last sale
IEX last saleClose of record
Last sale prices: Data provided for free by IEX. By accessing or using IEX Historical Data, you agree to the IEX Historical Data Terms of Use.
Financials
Net Interest Income
| Period | Ended | Value | Kind | Source trail |
|---|---|---|---|---|
| FY 2025 | 2025-12-31 | $510,000 | reported | |
| FY 2024 | 2024-12-31 | $920,000 | reported | |
| FY 2023 | 2023-12-31 | $461,000 | reported | |
| FY 2021 | 2021-12-31 | $14,000 | reported | |
| FY 2020 | 2020-12-31 | $39,000 | reported | |
| FY 2019 | 2019-12-31 | $22,000 | reported | |
| FY 2018 | 2018-12-31 | $40,000 revised | reported | |
| FY 2017 | 2017-12-31 | $286,000 | reported | |
| FY 2016 | 2016-12-31 | $114,000 | reported | |
| FY 2015 | 2015-12-31 | $762,000 | reported | |
| FY 2014 | 2014-12-31 | $55,000 | reported |
Pharmaceutical preparations
MetaVia Inc. is the 423rd largest of the 553 covered companies the SEC files under this code, by market cap. SIC 2834
CompanyRevenueGrowthNet marginMarket cap
PHIOPhio Pharmaceuticals Corp.———$9.6MINBPIntegrated Biopharma Inc$43.9M19.3%6.5%$9.1MAEMDAethlon Medical Inc———$8.8MRKTORocket One Inc.———$8.8M
MTVAMetaVia Inc. (this company)———$8.8M
MBRXMoleculin Biotech, Inc.$0.0——$8.7MCALCCalciMedica, Inc.———$8.6MCURXCuranex Pharmaceuticals Inc———$8.4MVTGNVistagen Therapeutics, Inc.$1.3M161.1%5,491.3%$8.2MPeers are the covered companies filed under the same SIC code, then under codes that share its first three digits or its first two, nearest in market cap first. Figures are each company’s latest fiscal year as filed; market cap is at its latest price.
MetaVia Inc. · CIK 1638287 · Engraved from SEC EDGAR